Candriam S.C.A. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5,912,851
-24.6%
220,0540.0%0.04%
-26.3%
Q2 2023$7,847,126
+16.5%
220,054
-23.6%
0.06%
+21.3%
Q1 2023$6,734,384
-53.6%
288,054
-19.6%
0.05%
-52.0%
Q4 2022$14,521,990
-1.9%
358,054
-20.1%
0.10%
-5.8%
Q3 2022$14,809,000
+10.9%
448,054
+18.1%
0.10%
-5.5%
Q2 2022$13,357,000
+7.6%
379,365
+40.5%
0.11%
+29.4%
Q1 2022$12,419,000
+216.5%
270,054
+356.3%
0.08%
+240.0%
Q4 2021$3,924,000
-68.0%
59,187
-69.9%
0.02%
-69.9%
Q3 2021$12,261,000
-24.6%
196,4080.0%0.08%
-25.2%
Q2 2021$16,267,000
+34.6%
196,408
+19.8%
0.11%
+9.9%
Q1 2021$12,084,000
-4.0%
163,9580.0%0.10%
+1.0%
Q4 2020$12,581,000
+7.8%
163,958
-39.5%
0.10%
-9.1%
Q3 2020$11,675,000
-15.8%
271,146
-15.6%
0.11%
-24.7%
Q2 2020$13,871,000
-20.8%
321,146
+13.7%
0.15%
-24.7%
Q1 2020$17,517,000
-2.2%
282,5080.0%0.19%
+1.0%
Q4 2019$17,919,000
-18.9%
282,508
-64.0%
0.19%
-34.5%
Q3 2019$22,093,000
+58.3%
784,000
+48.2%
0.29%
+68.4%
Q2 2019$13,957,000
+28.0%
529,000
-10.9%
0.17%
+25.2%
Q1 2019$10,900,000
+47.8%
594,0000.0%0.14%
+23.0%
Q4 2018$7,377,000
-25.1%
594,000
+15.6%
0.11%
-13.7%
Q3 2018$9,853,000514,0000.13%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders